These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 36072979)
21. Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer. Liang Y; Ye F; Cheng Z; Ou Y; Zou L; Hu Y; Hu J; Jiang H Cancer Cell Int; 2021 Sep; 21(1):476. PubMed ID: 34496843 [TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of Genomic Instability of m Li R; Li JP; Liu TT; Huo C; Yao J; Ji XL; Qu YQ Front Cell Dev Biol; 2022; 10():707405. PubMed ID: 35309906 [No Abstract] [Full Text] [Related]
23. Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma. Peng B; Li H; Na R; Lu T; Li Y; Zhao J; Zhang H; Zhang L Front Cell Dev Biol; 2021; 9():706454. PubMed ID: 34336859 [TBL] [Abstract][Full Text] [Related]
24. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
25. Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma. Yang X; Mei M; Yang J; Guo J; Du F; Liu S Aging (Albany NY); 2022 May; 14(9):4069-4084. PubMed ID: 35550563 [TBL] [Abstract][Full Text] [Related]
26. Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinoma. Xun Z; Wang Y; Long J; Li Y; Yang X; Sun H; Zhao H Front Genet; 2022; 13():1034979. PubMed ID: 36712850 [TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma. Cao J; Wu L; Lei X; Shi K; Shi L; Shi Y Bioengineered; 2021 Dec; 12(1):673-681. PubMed ID: 33622186 [TBL] [Abstract][Full Text] [Related]
28. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma. Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420 [TBL] [Abstract][Full Text] [Related]
29. Genomic instability-associated lncRNA signature predicts prognosis and distinct immune landscape in gastric cancer. Sun J; Jiang Q; Chen H; Zhang Q; Zhao J; Li H; Wang X; Fang Y; Ruan Y; Sun Y Ann Transl Med; 2021 Aug; 9(16):1326. PubMed ID: 34532463 [TBL] [Abstract][Full Text] [Related]
30. Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma. Tang X; Miao Y; Wang J; Cai T; Yang L; Mi D Comput Math Methods Med; 2021; 2021():1205029. PubMed ID: 34840594 [TBL] [Abstract][Full Text] [Related]
31. M6A-related lncRNAs predict clinical outcome and regulate the tumor immune microenvironment in hepatocellular carcinoma. Chen B; Yang Z; Lang Z; Tao Q; Zhang R; Zhan Y; Xu X; Zhu K; Zheng J; Yu Z; Yu S BMC Cancer; 2022 Aug; 22(1):867. PubMed ID: 35941582 [TBL] [Abstract][Full Text] [Related]
32. Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis. Wang X; Zhang H; Ye J; Gao M; Jiang Q; Zhao T; Wang S; Mao W; Wang K; Wang Q; Chen X; Hou X; Han D Front Genet; 2022; 13():850888. PubMed ID: 35571034 [TBL] [Abstract][Full Text] [Related]
33. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma. Bai Y; Lin H; Chen J; Wu Y; Yu S Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985 [No Abstract] [Full Text] [Related]
34. Development and Validation of Genome Instability-Associated lncRNAs to Predict Prognosis and Immunotherapy of Patients With Hepatocellular Carcinoma. Yan Y; Ren L; Liu Y; Liu L Front Genet; 2021; 12():763281. PubMed ID: 35154241 [TBL] [Abstract][Full Text] [Related]
35. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y Front Immunol; 2021; 12():719175. PubMed ID: 34603293 [TBL] [Abstract][Full Text] [Related]
36. Increased long noncoding RNA LINC00511 is correlated with poor prognosis and contributes to cell proliferation and metastasis by modulating miR-424 in hepatocellular carcinoma. Wang RP; Jiang J; Jiang T; Wang Y; Chen LX Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3291-3301. PubMed ID: 31081082 [TBL] [Abstract][Full Text] [Related]
37. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
38. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Li L; Xie R; Lu G Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555 [TBL] [Abstract][Full Text] [Related]
39. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma. Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL Front Oncol; 2020; 10():780. PubMed ID: 32587825 [No Abstract] [Full Text] [Related]
40. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]